ARTICLE | Product Development
BioCentury’s analysis of the SITC, ASH abstracts highlights progress in bicistronic and tandem CAR Ts
By Lauren Martz, Executive Director, Biopharma Intelligence
November 21, 2024 10:22 PM UTC
Of all the ways that CAR T cell structures are being optimized to improve efficacy in hematological cancers and make the transition to solid tumors, multi-targeting designs are emerging as some of the most promising.
A series of abstracts released ahead of two fall meetings, the American Society of Hematology (ASH) and Society for Immunotherapy of Cancer (SITC) annual conferences, highlight methods for applying dual or bispecific CAR T cell designs to solid tumors, and provide updates on clinical progress in hematological indications. …
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654250/companies-get-creative-with-multi-targeted-cars-at-sitc-ash